East Coast fever, a neglected tropical disease with an outdated vaccine approach?

Kolakowski, Jeannine; Lukacik, P.; Pfuhl, Mark; Werling, Dirk

doi:10.1016/j.pt.2022.08.006

Cited by 4 publications

(3 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Kolakowski et al [ 157 ] recently reviewed ECF vaccine development, highlighting three aspects of T. parva biology that have been largely neglected. The first of these is the poor understanding of host cell invasion and the potential importance that post-translation modifications could play in this process.…”

Section: Development Of Mrna Vaccines For Important Livestock Diseasesmentioning

confidence: 99%

“…The second knowledge gap identified was the lack of understanding of the T. parva proteomes of each live stage, and therefore the potential repertoire of candidate antigens [ 157 ]. Using comparative transcriptomes and bioinformatic analyses, Atchou et al [ 159 ] identified several novel candidate antigens.…”

Section: Development Of Mrna Vaccines For Important Livestock Diseasesmentioning

confidence: 99%

“…The third knowledge gap identified was the poor understanding of what constitutes a protective immune response [ 157 ]. It is generally accepted that strong cell-mediated responses play crucial roles in providing protection from and reducing the severity of T. parva -associated disease.…”

Section: Development Of Mrna Vaccines For Important Livestock Diseasesmentioning

confidence: 99%

See 2 more Smart Citations

Can the Revolution in mRNA-Based Vaccine Technologies Solve the Intractable Health Issues of Current Ruminant Production Systems?

Mahony,

Briody,

Ommeh

2024

Vaccines

View full text Add to dashboard Cite

To achieve the World Health Organization’s global Sustainable Development Goals, increased production of high-quality protein for human consumption is required while minimizing, ideally reducing, environmental impacts. One way to achieve these goals is to address losses within current livestock production systems. Infectious diseases are key limiters of edible protein production, affecting both quantity and quality. In addition, some of these diseases are zoonotic threats and potential contributors to the emergence of antimicrobial resistance. Vaccination has proven to be highly successful in controlling and even eliminating several livestock diseases of economic importance. However, many livestock diseases, both existing and emerging, have proven to be recalcitrant targets for conventional vaccination technologies. The threat posed by the COVID-19 pandemic resulted in unprecedented global investment in vaccine technologies to accelerate the development of safe and efficacious vaccines. While several vaccination platforms emerged as front runners to meet this challenge, the clear winner is mRNA-based vaccination. The challenge now is for livestock industries and relevant stakeholders to harness these rapid advances in vaccination to address key diseases affecting livestock production. This review examines the key features of mRNA vaccines, as this technology has the potential to control infectious diseases of importance to livestock production that have proven otherwise difficult to control using conventional approaches. This review focuses on the challenging diseases of ruminants due to their importance in global protein production. Overall, the current literature suggests that, while mRNA vaccines have the potential to address challenges in veterinary medicine, further developments are likely to be required for this promise to be realized for ruminant and other livestock species.

show abstract

Section: Development Of Mrna Vaccines For Important Livestock Diseasesmentioning

confidence: 99%

Section: Development Of Mrna Vaccines For Important Livestock Diseasesmentioning

confidence: 99%